BUZZ-U.S. STOCKS ON THE MOVE-Capricor, Plasmatech, Maxlinear, Walter Energy,

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. stocks dipped slightly at the open on Monday as investors worried about the prospect of the Federal Reserve raising interest rates as soon as September, after Friday's strong jobs report. The Dow Jones industrial average was down 0.13 percent at 17,826.84, the S&P 500 was down 0.09 percent at 2,090.93 and the Nasdaq Composite was down 0.11 percent at 5,062.737.

** CAPRICOR THERAPEUTICS INC (NasdaqCM: CAPR - news) , $7.785, +29.97 pct

The drug developer gets FDA clearance to conduct clinical trials on its cell therapy, CAP-1002, to treat heart failure in patients with DMD, a muscle wasting disorder.

** PLASMATECH BIOPHARMACEUTICALS INC (Stuttgart: PCJP.SG - news) , $7.7735, +6.49 pct

The cell therapy developer bought rights to a new gene therapy to treat rare diseases from the University of Nebraska Medical Center.

** MAXLINEAR INC (NYSE: MXL - news) , $11.16, +4.30 pct

George Soros-controlled Soros Fund Management LLC reports a passive stake of 5.19 pct in the radio frequency chip maker as of May 26.

** WALTER ENERGY INC (NYSE: WLT - news) , $0.36, -20.00 pct

The U.S. coal miner Walter Energy Inc could file for bankruptcy protection as soon as this month, Bloomberg reported on Friday, citing sources close to the matter.

** DEUTSCHE BANK (Xetra: 514000 - news) , $32.34, +5.58 pct

Germany's largest lender Deutsche Bank purged its leadership on Sunday, appointing Briton John Cryan as chief executive to replace Anshu Jain just two weeks after Jain was given more power to reorganise the bank.

** MCDONALD'S CORP, $95.57, +0.03 pct

The company posted a smaller-than-expected decline in worldwide sales at established restaurants in May as strong sales in Europe more than offset a decline in the United States.

** GALAPAGOS NV (Brussels: GLPG.BR - news) , $55.67, +6.91 pct

Morgan Stanley (Xetra: 885836 - news) initiated coverage of the Belgian biotech group's stock with an "overweight" recommendation. "We believe Galapagos offers a differentiated pipeline with access to large market opportunities including rheumatoid arthritis and cystic fibrosis," Morgan Stanley analysts wrote in a note to clients.

** BALLARD POWER SYSTEMS (Toronto: BLD.TO - news) , $2.2726, +8.22 pct

The fuel-cell products maker signed a $10 million contract with two Chinese electric bus makers for 33 fuel-cell powered buses.

** SHIRE PLC (Xetra: S7E.DE - news) , $245.93, -2.22 pct

Shares (Berlin: DI6.BE - news) in Actelion (Xetra: 936767 - news) , Europe's biggest biotech company, jumped 7 percent to a record high on Monday after a report Shire was considering a $18 billion takeover of the Swiss group to boost its rare diseases business. A spokeswoman for Shire, whose shares fell 2 percent, told Reuters the company did not comment on speculation.

** TESLA MOTORS INC (Xetra: A1CX3T - news) , $255.05, +2.37 pct

Japanese electronics group Panasonic Corp plans to send hundreds of its employees to Tesla's Gigafactory in Nevada from this autumn to prepare for production at the plant, which it confirmed will start sometime next year.

Baird raised price target on the company's stock to $335 from $275.

** AMERICAN AIRLINES GROUP INC, $40.995, -1.74 pct

The company Chief Executive Doug Parker voiced concern on Sunday about the risk that capacity growth among airlines could depress profits, but told Reuters that in contrast with past cycles, the rise in capacity "feels different." (Compiled By Manya Venkatesh in Bengaluru; Edited by Don Sebastian)